Panacos Pharmaceuticals - Dividend History | PANC
Historical dividend payout and yield for Panacos Pharmaceuticals (PANC) since 1971. The current TTM dividend payout for Panacos Pharmaceuticals (PANC) as of December 31, 1969 is $0.00. The current dividend yield for Panacos Pharmaceuticals as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.000B |
|
Panacos Pharmaceuticals, Inc. is developing the next generation of anti-infective products. Panacos' proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus fusion. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Based on its novel mechanism of action, bevirimat is designed to have potent activity against a broad range of HIV, including strains that are resistant to existing classes of drugs. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
